Table S2. Shows all causative mutations identified in 72 patients from 68 families suffering from primary immunodeficiencies. (XLSX 17 kb
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S5. Quality information of the WES technology, with the mean target coverage, and the % of bas...
Table S5. Quality information of the WES technology, with the mean target coverage, and the % of bas...
Table S2. Shows all causative mutations identified in 72 patients from 68 families suffering from pr...
Table S6. Information on all large >â 5-Mb homozygous regions per patient, detected in the exome....
Table S6. Information on all large >â 5-Mb homozygous regions per patient, detected in the exome....
Table S6. Information on all large >â 5-Mb homozygous regions per patient, detected in the exome....
Table S6. Information on all large >â 5-Mb homozygous regions per patient, detected in the exome....
Table S4. (A) The number of patients with isolated or combined infections, and (B) the number of pat...
Table S4. (A) The number of patients with isolated or combined infections, and (B) the number of pat...
Table S1. Overview of all clinical characteristics of the patients included in our diagnostic PID co...
Table S1. Overview of all clinical characteristics of the patients included in our diagnostic PID co...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S5. Quality information of the WES technology, with the mean target coverage, and the % of bas...
Table S5. Quality information of the WES technology, with the mean target coverage, and the % of bas...
Table S2. Shows all causative mutations identified in 72 patients from 68 families suffering from pr...
Table S6. Information on all large >â 5-Mb homozygous regions per patient, detected in the exome....
Table S6. Information on all large >â 5-Mb homozygous regions per patient, detected in the exome....
Table S6. Information on all large >â 5-Mb homozygous regions per patient, detected in the exome....
Table S6. Information on all large >â 5-Mb homozygous regions per patient, detected in the exome....
Table S4. (A) The number of patients with isolated or combined infections, and (B) the number of pat...
Table S4. (A) The number of patients with isolated or combined infections, and (B) the number of pat...
Table S1. Overview of all clinical characteristics of the patients included in our diagnostic PID co...
Table S1. Overview of all clinical characteristics of the patients included in our diagnostic PID co...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Table S5. Quality information of the WES technology, with the mean target coverage, and the % of bas...
Table S5. Quality information of the WES technology, with the mean target coverage, and the % of bas...